心脉隆注射液与多种药物治疗心力衰竭的疗效和安全性分析  

Analysis of efficacy and safety of Xinmai Long Injection and various drug s in the treatment of heart failure

作　　者：周杨 彭芳 Zhou Yang;Peng Fang(College of Pharmacy and Chemistry,Dali University,Dali 671000)

机构地区：[1]大理大学药学与化学院,云南大理671000

出　　处：《当代医药论丛》2020年第13期60-63,共4页

基　　金：国家自然科学基金项目(81560600)。

摘　　要：心力衰竭(heart failure)是一种发病率较高的心血管疾病。心脉隆注射液是一种具有益气活血、通阳利水功效的中成药。近年来,临床上用心脉隆注射液联合强心剂、β受体阻滞剂、利尿剂等药物治疗心力衰竭,取得了良好的效果。本文主要是研究用心脉隆注射液联合多种药物治疗心力衰竭的效果及安全性。Heart failure is a kind of cardiovascular disease with high incidence.Xinmaulong injection is a kind of Chinese patent medicine with beneficial effect of activating qi and blood circulation and promoting Yang and benefiting water.In recent years,the combination of xinmai Long injection with cardiac stimulants,beta blockers,diuretics and other drugs in the treatment of heart failure has achieved good results.This paper mainly studies the efficacy and safety of Xinmai Long injection combined with multiple drugs in the treatment of heart failure.

关 键 词：心脉隆注射液 利尿剂 Β受体阻滞剂 胺碘酮 曲美他嗪 心力衰竭 安全性 

分 类 号：R541.6[医药卫生—心血管疾病]